Report for Siripurapu KB

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (10)

Title : The vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuse - Nickell_2014_Adv.Pharmacol_69_71
Author(s) : Nickell JR , Siripurapu KB , Vartak A , Crooks PA , Dwoskin LP
Ref : Advances in Pharmacology , 69 :71 , 2014
Abstract : Nickell_2014_Adv.Pharmacol_69_71
ESTHER : Nickell_2014_Adv.Pharmacol_69_71
PubMedSearch : Nickell_2014_Adv.Pharmacol_69_71
PubMedID: 24484975

Title : Structural modifications to tetrahydropyridine-3-carboxylate esters en route to the discovery of M5-preferring muscarinic receptor orthosteric antagonists - Zheng_2013_J.Med.Chem_56_1693
Author(s) : Zheng G , Smith AM , Huang X , Subramanian KL , Siripurapu KB , Deaciuc A , Zhan CG , Dwoskin LP
Ref : Journal of Medicinal Chemistry , 56 :1693 , 2013
Abstract : Zheng_2013_J.Med.Chem_56_1693
ESTHER : Zheng_2013_J.Med.Chem_56_1693
PubMedSearch : Zheng_2013_J.Med.Chem_56_1693
PubMedID: 23379472

Title : Potential therapeutic uses of mecamylamine and its stereoisomers - Nickell_2013_Pharmacol.Biochem.Behav_108_28
Author(s) : Nickell JR , Grinevich VP , Siripurapu KB , Smith AM , Dwoskin LP
Ref : Pharmacol Biochem Behav , 108 :28 , 2013
Abstract : Nickell_2013_Pharmacol.Biochem.Behav_108_28
ESTHER : Nickell_2013_Pharmacol.Biochem.Behav_108_28
PubMedSearch : Nickell_2013_Pharmacol.Biochem.Behav_108_28
PubMedID: 23603417

Title : meso-Transdiene analogs inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine release - Horton_2011_J.Pharmacol.Exp.Ther_336_940
Author(s) : Horton DB , Siripurapu KB , Norrholm SD , Culver JP , Hojahmat M , Beckmann JS , Harrod SB , Deaciuc AG , Bardo MT , Crooks PA , Dwoskin LP
Ref : Journal of Pharmacology & Experimental Therapeutics , 336 :940 , 2011
Abstract : Horton_2011_J.Pharmacol.Exp.Ther_336_940
ESTHER : Horton_2011_J.Pharmacol.Exp.Ther_336_940
PubMedSearch : Horton_2011_J.Pharmacol.Exp.Ther_336_940
PubMedID: 21177475

Title : Novel N-1,2-dihydroxypropyl analogs of lobelane inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine release - Horton_2011_J.Pharmacol.Exp.Ther_339_286
Author(s) : Horton DB , Siripurapu KB , Zheng G , Crooks PA , Dwoskin LP
Ref : Journal of Pharmacology & Experimental Therapeutics , 339 :286 , 2011
Abstract : Horton_2011_J.Pharmacol.Exp.Ther_339_286
ESTHER : Horton_2011_J.Pharmacol.Exp.Ther_339_286
PubMedSearch : Horton_2011_J.Pharmacol.Exp.Ther_339_286
PubMedID: 21778282

Title : bPiDI: a novel selective alpha6beta2* nicotinic receptor antagonist and preclinical candidate treatment for nicotine abuse - Wooters_2011_Br.J.Pharmacol_163_346
Author(s) : Wooters TE , Smith AM , Pivavarchyk M , Siripurapu KB , McIntosh JM , Zhang Z , Crooks PA , Bardo MT , Dwoskin LP
Ref : British Journal of Pharmacology , 163 :346 , 2011
Abstract : Wooters_2011_Br.J.Pharmacol_163_346
ESTHER : Wooters_2011_Br.J.Pharmacol_163_346
PubMedSearch : Wooters_2011_Br.J.Pharmacol_163_346
PubMedID: 21232049

Title : The novel pyrrolidine nor-lobelane analog UKCP-110 [cis-2,5-di-(2-phenethyl)-pyrrolidine hydrochloride] inhibits VMAT2 function, methamphetamine-evoked dopamine release, and methamphetamine self-administration in rats - Beckmann_2010_J.Pharmacol.Exp.Ther_335_841
Author(s) : Beckmann JS , Siripurapu KB , Nickell JR , Horton DB , Denehy ED , Vartak A , Crooks PA , Dwoskin LP , Bardo MT
Ref : Journal of Pharmacology & Experimental Therapeutics , 335 :841 , 2010
Abstract : Beckmann_2010_J.Pharmacol.Exp.Ther_335_841
ESTHER : Beckmann_2010_J.Pharmacol.Exp.Ther_335_841
PubMedSearch : Beckmann_2010_J.Pharmacol.Exp.Ther_335_841
PubMedID: 20805303

Title : Lobelane inhibits methamphetamine-evoked dopamine release via inhibition of the vesicular monoamine transporter-2 - Nickell_2010_J.Pharmacol.Exp.Ther_332_612
Author(s) : Nickell JR , Krishnamurthy S , Norrholm S , Deaciuc G , Siripurapu KB , Zheng G , Crooks PA , Dwoskin LP
Ref : Journal of Pharmacology & Experimental Therapeutics , 332 :612 , 2010
Abstract : Nickell_2010_J.Pharmacol.Exp.Ther_332_612
ESTHER : Nickell_2010_J.Pharmacol.Exp.Ther_332_612
PubMedSearch : Nickell_2010_J.Pharmacol.Exp.Ther_332_612
PubMedID: 19855096

Title : The novel nicotinic receptor antagonist, N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB), inhibits nicotine-evoked [(3)H]norepinephrine overflow from rat hippocampal slices - Smith_2009_Biochem.Pharmacol_78(7)_889
Author(s) : Smith AM , Dhawan GK , Zhang Z , Siripurapu KB , Crooks PA , Dwoskin LP
Ref : Biochemical Pharmacology , 78 :889 , 2009
Abstract : Smith_2009_Biochem.Pharmacol_78(7)_889
ESTHER : Smith_2009_Biochem.Pharmacol_78(7)_889
PubMedSearch : Smith_2009_Biochem.Pharmacol_78(7)_889
PubMedID: 19631612

Title : N,N'-Alkane-diyl-bis-3-picoliniums as nicotinic receptor antagonists: inhibition of nicotine-evoked dopamine release and hyperactivity - Dwoskin_2008_J.Pharmacol.Exp.Ther_326_563
Author(s) : Dwoskin LP , Wooters TE , Sumithran SP , Siripurapu KB , Joyce BM , Lockman PR , Manda VK , Ayers JT , Zhang Z , Deaciuc AG , McIntosh JM , Crooks PA , Bardo MT
Ref : Journal of Pharmacology & Experimental Therapeutics , 326 :563 , 2008
Abstract : Dwoskin_2008_J.Pharmacol.Exp.Ther_326_563
ESTHER : Dwoskin_2008_J.Pharmacol.Exp.Ther_326_563
PubMedSearch : Dwoskin_2008_J.Pharmacol.Exp.Ther_326_563
PubMedID: 18460644